Table 4.
Serological and molecular profiles in blood donor samples identified as possible OBI.
| Number | ID | 1st RDT | 2nd RDT | qHBsAg | qHBsAg | Anti-HBc | Anti-HBc | HBV DNA |
|---|---|---|---|---|---|---|---|---|
| Determine® | Vikia® | Liason® | IU/mL | IgG | IgM | IU/mL | ||
| 1 | 241 | n | n | n | 0.036 | n | n | 272 |
| 2 | 249 | n | n | n | <0.030 | n | - | 18 |
| 3 | 284 | n | n | n | <0.030 | n | n | <10 |
| 4 | 349 | n | n | n | <0.030 | p | - | 13 |
| 5 | 389 | n | n | n | <0.030 | p | - | 38 |
OBI, occult hepatitis B infection; ID, sample identification; RDT, rapid diagnostic test; qHBsAg, quantitative surface antigen test; anti-HBc, hepatitis B core antibody; IU/mL, international units per millilitre; IgG, immunoglobulin class G; IgM, immunoglobulin class M; n, negative; p, positive.